Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12200137rdf:typepubmed:Citationlld:pubmed
pubmed-article:12200137lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:12200137lifeskim:mentionsumls-concept:C0034819lld:lifeskim
pubmed-article:12200137lifeskim:mentionsumls-concept:C1514762lld:lifeskim
pubmed-article:12200137lifeskim:mentionsumls-concept:C0599697lld:lifeskim
pubmed-article:12200137pubmed:issue4lld:pubmed
pubmed-article:12200137pubmed:dateCreated2002-8-29lld:pubmed
pubmed-article:12200137pubmed:abstractTextInterleukin-2 induces heterodimerization of the IL-2 receptor beta and gamma subunits. This study addresses a role of the Shb adapter protein in IL-2 receptor signaling in T and NK cells. The IL-2Rbeta and gamma chains were found to co-immunoprecipitate with Shb, when each alone was co-expressed with Shb in COS cells. Using fusion proteins, the Shb SH2 domain was found to associate in a phosphotyrosine-dependent manner with the IL-2 receptor beta and gamma subunits upon IL-2 stimulation in primary T cells and the NK cell line NK-92. The main binding site of the Shb SH2 domain was phosphorylated Tyr-510 in the IL-2Rbeta chain. Shb was also phosphorylated upon IL-2 stimulation when overexpressed together with IL-2Rbeta (in pre-B cells, which express the gamma chain constitutively). These cells were also less apoptotic in the presence of IL-2 than cells overexpressing a mutant Shb (with a defect SH2 domain) or cells expressing a mutant IL-2Rbeta, with the Shb binding sites mutated to phenylalanine (Y392F, Y510F). JAK1 and JAK3 were also found to associate with Shb, but in contrast to the Shb-IL-2 receptor association, JAK1 and 3 appear to associate with the proline-rich regions of Shb. In conclusion, Shb links the IL-2 receptor to other signaling proteins and mediates the regulation of apoptosis in the presence of IL-2.lld:pubmed
pubmed-article:12200137pubmed:languageenglld:pubmed
pubmed-article:12200137pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:citationSubsetIMlld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12200137pubmed:statusMEDLINElld:pubmed
pubmed-article:12200137pubmed:monthAuglld:pubmed
pubmed-article:12200137pubmed:issn0006-291Xlld:pubmed
pubmed-article:12200137pubmed:authorpubmed-author:LindholmCecil...lld:pubmed
pubmed-article:12200137pubmed:issnTypePrintlld:pubmed
pubmed-article:12200137pubmed:day30lld:pubmed
pubmed-article:12200137pubmed:volume296lld:pubmed
pubmed-article:12200137pubmed:ownerNLMlld:pubmed
pubmed-article:12200137pubmed:authorsCompleteYlld:pubmed
pubmed-article:12200137pubmed:pagination929-36lld:pubmed
pubmed-article:12200137pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:meshHeadingpubmed-meshheading:12200137...lld:pubmed
pubmed-article:12200137pubmed:year2002lld:pubmed
pubmed-article:12200137pubmed:articleTitleIL-2 receptor signaling through the Shb adapter protein in T and NK cells.lld:pubmed
pubmed-article:12200137pubmed:affiliationDepartment of Medical Cell Biology, Uppsala University, Biomedicum, Box 571, S-75123 Uppsala, Sweden. Cecilia.Lindholm@medcellbiol.uu.selld:pubmed
pubmed-article:12200137pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12200137pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3560entrezgene:pubmedpubmed-article:12200137lld:entrezgene
entrez-gene:3561entrezgene:pubmedpubmed-article:12200137lld:entrezgene
entrez-gene:3716entrezgene:pubmedpubmed-article:12200137lld:entrezgene
entrez-gene:3718entrezgene:pubmedpubmed-article:12200137lld:entrezgene
entrez-gene:3640entrezgene:pubmedpubmed-article:12200137lld:entrezgene
entrez-gene:6461entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12200137lld:entrezgene